Status:
UNKNOWN
Effect of a Hydrogen-Peroxide and Hyaluronic-Acid Mouthwash (BMG0703) in the Treatment of Periodontitis
Lead Sponsor:
University of Milan
Collaborating Sponsors:
BMG Pharma
Conditions:
Periodontitis
Bleeding Gum
Eligibility:
All Genders
18-50 years
Phase:
PHASE3
Brief Summary
Assessment of the efficacy of BMG0703 in the treatment of periodontitis and control of supragingival plaque, compared to Chlorhexidine and a placebo product
Detailed Description
The enrolled subjects will be examined and treated by specialized medical personnel. Patients will undergo a professional oral hygiene session (causal therapy) and will be instructed to perform prope...
Eligibility Criteria
Inclusion
- Presence of periodontitis with pockets between 3 and 7 mm
- Acceptance of informed consent
Exclusion
- subjects suffering from HIV
- subjects suffering from hepatitis
- serious systemic diseases preventing the use of specific dental therapies
- acute and/or chronic infectious pathologies
- inability to provide consent
- use of topical or systemic drugs
- inability to follow post-intervention hygiene instructions
- smokers
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04446533
Start Date
June 1 2020
End Date
July 1 2020
Last Update
June 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UOC Maxillofacial Surgery and Odontology, University of Milan
Milan, Lombardy, Italy, 20122